Roche Lunsumio Receives Priority Review From US FDA
ADC评论
July 7, 2022
Basel, 6 July 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s
